NASDAQ:RCM - R1 RCM Stock Price, Price Target & More

$8.04 +0.54 (+7.20 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$8.04
Today's Range$7.50 - $8.20
52-Week Range$3.05 - $8.20
Volume1.09 million shs
Average Volume378,781 shs
Market Capitalization$763.85 million
P/E Ratio-18.27
Dividend YieldN/A
Beta-0.75

About R1 RCM (NASDAQ:RCM)

R1 RCM logoR1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820

Debt

Debt-to-Equity RatioN/A
Current Ratio2.25%
Quick Ratio2.25%

Price-To-Earnings

Trailing P/E Ratio-18.27
Forward P/E Ratio-53.60
P/E GrowthN/A

Sales & Book Value

Annual Sales$449.80 million
Price / Sales1.86
Cash FlowN/A
Price / CashN/A
Book Value$0.32 per share
Price / Book25.13

Profitability

EPS (Most Recent Fiscal Year)($0.44)
Net Income$-58,800,000.00
Net Margins-13.07%
Return on Equity-31.68%
Return on Assets-6.42%

Miscellaneous

Employees9,965
Outstanding Shares104,070,000

How to Become a New Pot Stock Millionaire

R1 RCM (NASDAQ:RCM) Frequently Asked Questions

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) released its quarterly earnings results on Friday, March, 9th. The financial services provider reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.07. The financial services provider had revenue of $140.30 million for the quarter, compared to analysts' expectations of $131.20 million. R1 RCM had a negative return on equity of 31.68% and a negative net margin of 13.07%. View R1 RCM's Earnings History.

When is R1 RCM's next earnings date?

R1 RCM is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for R1 RCM.

What price target have analysts set for RCM?

3 equities research analysts have issued 1-year price targets for R1 RCM's shares. Their forecasts range from $9.00 to $10.00. On average, they anticipate R1 RCM's share price to reach $9.3333 in the next twelve months. View Analyst Ratings for R1 RCM.

What are Wall Street analysts saying about R1 RCM stock?

Here are some recent quotes from research analysts about R1 RCM stock:
  • 1. Cantor Fitzgerald analysts commented, "The revenue cycle management market represents a significant opportunity. Revenue cycle management remains an underdeveloped and fragmented market. There are many different solutions available, including consulting arrangements, point-solution technologies, and transactional outsourcing. Many providers use fragmented solutions. As a result, healthcare organizations are increasingly dissatisfied with currently available options and see a strong commercial partner to help improve performance and increase ROI. We estimate the market opportunity will increase to almost $70 billion by 2020. In addition, increasing consolidation among providers should lead to additional outsourcing. We expect revenue cycle outsourcing to grow to $7.7 billion by 2020 from $3.8 billion in 2015. We estimate the ambulatory market opportunity is approximately $30-40 billion. As hospital systems acquire physician offices, we expect the ambulatory market opportunity to expand." (3/13/2018)
  • 2. According to Zacks Investment Research, "R1 RCM Inc. offers financial services for the health care industries. The Company provides revenue cycle management and physician advisory services, as well as transforms and manages the commercial infrastructure of health care organizations. R1 RCM Inc., formerly known as Accretive Health, Inc., is headquartered in Chicago, Illinois. " (3/1/2018)

Who are some of R1 RCM's key competitors?

Who are R1 RCM's key executives?

R1 RCM's management team includes the folowing people:
  • Steven J. Shulman, Chairman of the Board , Independent Director (Age 65)
  • Joseph Gerard Flanagan, President, Chief Executive Officer, Director (Age 45)
  • Christopher Simon Ricaurte, Chief Financial Officer, Treasurer (Age 57)
  • Thomas A. Lesica, Chief Operating Officer, Executive Vice President (Age 57)
  • Gary Steven Long, Executive Vice President, Chief Commercial Officer
  • Michael C. Feiner, Director (Age 74)
  • John Bell Henneman III, Director (Age 55)
  • Joseph R. Impicciche, Director (Age 59)
  • Neal Moszkowski, Director (Age 51)
  • Ian R. Sacks, Director (Age 46)

Has R1 RCM been receiving favorable news coverage?

News stories about RCM stock have trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. R1 RCM earned a daily sentiment score of 0.10 on Accern's scale. They also gave news articles about the financial services provider an impact score of 45.31 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of R1 RCM?

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $8.04.

How big of a company is R1 RCM?

R1 RCM has a market capitalization of $763.85 million and generates $449.80 million in revenue each year. The financial services provider earns $-58,800,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis. R1 RCM employs 9,965 workers across the globe.

How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The financial services provider can be reached via phone at 312-324-7820 or via email at [email protected]


MarketBeat Community Rating for R1 RCM (RCM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  103 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  223
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

R1 RCM (NASDAQ:RCM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for R1 RCM in the last 12 months. Their average twelve-month price target is $9.3333, suggesting that the stock has a possible upside of 16.09%. The high price target for RCM is $10.00 and the low price target for RCM is $9.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.672.332.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.3333$8.6667$5.00$5.00
Price Target Upside: 16.09% upside15.86% upside44.72% upside44.72% upside

R1 RCM (NASDAQ:RCM) Consensus Price Target History

Price Target History for R1 RCM (NASDAQ:RCM)

R1 RCM (NASDAQ:RCM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/9/2018Robert W. BairdUpgradeNeutral -> Outperform$9.00MediumView Rating Details
3/13/2018Cantor FitzgeraldInitiated CoverageOverweight$9.00MediumView Rating Details
3/12/2018CowenReiterated RatingOutperform -> In-Line$5.00 -> $10.00MediumView Rating Details
(Data available from 4/21/2016 forward)

Earnings

R1 RCM (NASDAQ:RCM) Earnings History and Estimates Chart

Earnings by Quarter for R1 RCM (NASDAQ:RCM)

R1 RCM (NASDAQ:RCM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.15 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS

R1 RCM (NASDAQ RCM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018        
3/9/2018Q4 2017($0.01)($0.08)$131.20 million$140.30 millionViewListenView Earnings Details
10/31/2017Q3 2017($0.03)($0.08)$109.80 million$123.20 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.04)($0.11)$91.95 million$99.40 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.04)($0.12)$74.10 million$86.90 millionViewListenView Earnings Details
3/1/2017Q4 2016($0.03)$0.05$67.10 million$106.16 millionViewN/AView Earnings Details
11/2/2016Q3 2016$0.18$48.10 million$125.54 millionViewN/AView Earnings Details
8/4/2016Q2 2016($0.08)($0.45)$43.50 million$8.67 millionViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.85$56.70 million$352.19 millionViewListenView Earnings Details
3/10/2016Q4$0.08$0.06$68.90 million$68.34 millionViewListenView Earnings Details
11/9/2015Q315$0.05($0.34)$60.39 million$15.80 millionViewListenView Earnings Details
8/5/2015Q215$0.02($0.27)$56.51 million$22.09 millionViewListenView Earnings Details
7/7/2015Q1 2015($0.32)$53.00 million$10.97 millionViewN/AView Earnings Details
6/23/2015($0.13)$0.19$12.96 millionViewListenView Earnings Details
11/7/2012Q312$0.05$0.06$231.06 million$223.10 millionViewN/AView Earnings Details
8/8/2012$0.08$0.03ViewN/AView Earnings Details
5/9/2012$0.06$0.06ViewN/AView Earnings Details
2/29/2012$0.16$0.17ViewN/AView Earnings Details
11/9/2011$0.12$0.11ViewN/AView Earnings Details
8/10/2011Q2 2011$0.07$0.08ViewN/AView Earnings Details
5/11/2011$0.04$0.04ViewN/AView Earnings Details
3/2/2011$0.09$0.09ViewN/AView Earnings Details
11/11/2010Q3 2010$0.03$0.03ViewN/AView Earnings Details
8/12/2010Q2 2010$0.04$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

R1 RCM (NASDAQ:RCM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

R1 RCM (NASDAQ RCM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 62.00%
Institutional Ownership Percentage: 48.95%
Insider Trading History for R1 RCM (NASDAQ:RCM)
Institutional Ownership by Quarter for R1 RCM (NASDAQ:RCM)

R1 RCM (NASDAQ RCM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2016John B Henneman IIIDirectorBuy50,000$1.80$90,000.00100View SEC Filing  
8/11/2016Alex MandlDirectorBuy200,000$1.59$318,000.0065,700View SEC Filing  
8/10/2016Joseph Gerard FlanaganCEOBuy100,000$1.56$156,000.001,431,814View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

R1 RCM (NASDAQ RCM) News Headlines

Source:
DateHeadline
R1 RCM Inc. -- Moodys assigns B2 CFR to R1; B1 to first-lien debt; outlook stableR1 RCM Inc. -- Moody's assigns B2 CFR to R1; B1 to first-lien debt; outlook stable
finance.yahoo.com - April 17 at 10:05 AM
R1 RCM (RCM) Cut to "Strong Sell" at Zacks Investment ResearchR1 RCM (RCM) Cut to "Strong Sell" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 12:01 PM
Analyst: R1 RCMs Momentum Will Continue To Build Over Next Several YearsAnalyst: R1 RCM's Momentum Will Continue To Build Over Next Several Years
finance.yahoo.com - April 10 at 10:10 AM
UPDATE: Baird Upgrades R1 RCM Inc (RCM) to OutperformUPDATE: Baird Upgrades R1 RCM Inc (RCM) to Outperform
www.streetinsider.com - April 9 at 9:59 AM
Robert W. Baird Upgrades R1 RCM (RCM) to "Outperform"Robert W. Baird Upgrades R1 RCM (RCM) to "Outperform"
www.americanbankingnews.com - April 9 at 8:12 AM
R1 RCM (RCM) Lifted to Buy at ValuEngineR1 RCM (RCM) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 10:07 AM
R1 RCM Inc (RCM) Given Consensus Rating of "Buy" by BrokeragesR1 RCM Inc (RCM) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 2 at 11:28 PM
Edited Transcript of RCM earnings conference call or presentation 9-Mar-18 1:00pm GMTEdited Transcript of RCM earnings conference call or presentation 9-Mar-18 1:00pm GMT
finance.yahoo.com - April 1 at 9:55 AM
Head-To-Head Analysis: Sodexo (SDXAY) vs. R1 RCM (RCM)Head-To-Head Analysis: Sodexo (SDXAY) vs. R1 RCM (RCM)
www.americanbankingnews.com - April 1 at 9:37 AM
Contrasting Mantech International (MANT) and R1 RCM (RCM)Contrasting Mantech International (MANT) and R1 RCM (RCM)
www.americanbankingnews.com - April 1 at 7:23 AM
BRIEF-R1 Appoints Alex Mandl As Lead DirectorBRIEF-R1 Appoints Alex Mandl As Lead Director
www.reuters.com - March 27 at 10:13 AM
R1 RCM (RCM) Lifted to Hold at Zacks Investment ResearchR1 RCM (RCM) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - March 24 at 2:45 PM
R1 RCM to Begin Trading on the Nasdaq Global MarketR1 RCM to Begin Trading on the Nasdaq Global Market
finance.yahoo.com - March 21 at 10:57 AM
LendingClub (LC) versus R1 RCM (RCM) Critical AnalysisLendingClub (LC) versus R1 RCM (RCM) Critical Analysis
www.americanbankingnews.com - March 21 at 5:34 AM
Intrepid Healthcare Services (IPCM) vs. R1 RCM (RCM) Financial ContrastIntrepid Healthcare Services (IPCM) vs. R1 RCM (RCM) Financial Contrast
www.americanbankingnews.com - March 14 at 5:04 AM
R1 RCM (RCM) Coverage Initiated at Cantor FitzgeraldR1 RCM (RCM) Coverage Initiated at Cantor Fitzgerald
www.americanbankingnews.com - March 13 at 7:28 PM
R1 RCM (RCM) Presents At 38th Annual Cowen And Company Healthcare Conference - SlideshowR1 RCM (RCM) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 13 at 6:04 PM
R1 RCM (RCM) Receives In-Line Rating from CowenR1 RCM (RCM) Receives In-Line Rating from Cowen
www.americanbankingnews.com - March 12 at 12:53 PM
R1 RCM (RCM) Upgraded by BidaskClub to "Strong-Buy"R1 RCM (RCM) Upgraded by BidaskClub to "Strong-Buy"
www.americanbankingnews.com - March 10 at 9:59 AM
R1 RCM (RCM) Posts  Earnings Results, Misses Estimates By $0.37 EPSR1 RCM (RCM) Posts Earnings Results, Misses Estimates By $0.37 EPS
www.americanbankingnews.com - March 9 at 11:46 PM
R1 RCM Reports Fourth Quarter and Full Year 2017 ResultsR1 RCM Reports Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - March 9 at 10:36 AM
Tamarack Advisers LP Has $1.76 Million Stake in R1 RCM Inc (RCM)Tamarack Advisers LP Has $1.76 Million Stake in R1 RCM Inc (RCM)
www.americanbankingnews.com - March 6 at 10:30 AM
R1 Announces New Patient Experience Solution for the Revenue CycleR1 Announces New Patient Experience Solution for the Revenue Cycle
finance.yahoo.com - March 5 at 10:05 AM
Continental Advisors LLC Has $1.20 Million Holdings in R1 RCM Inc (RCM)Continental Advisors LLC Has $1.20 Million Holdings in R1 RCM Inc (RCM)
www.americanbankingnews.com - March 4 at 5:30 AM
R1 RCM Inc (RCM) is SLS Management LLCs 6th Largest PositionR1 RCM Inc (RCM) is SLS Management LLC's 6th Largest Position
www.americanbankingnews.com - March 2 at 5:57 PM
R1 RCM (RCM) Scheduled to Post Earnings on FridayR1 RCM (RCM) Scheduled to Post Earnings on Friday
www.americanbankingnews.com - March 2 at 1:14 AM
R1 RCM IncR1 RCM Inc
www.bloomberg.com - February 28 at 4:45 PM
R1 RCM to Release Fourth Quarter 2017 Results on March 9R1 RCM to Release Fourth Quarter 2017 Results on March 9
finance.yahoo.com - February 28 at 9:39 AM
R1 RCMs (RCM) Hold Rating Reaffirmed at Robert W. BairdR1 RCM's (RCM) Hold Rating Reaffirmed at Robert W. Baird
www.americanbankingnews.com - February 27 at 12:40 AM
R1 RCM (RCM) to Acquire Intermedix for $460MR1 RCM (RCM) to Acquire Intermedix for $460M
www.streetinsider.com - February 26 at 4:45 PM
BRIEF-R1 RCM Says If Deal Terminated Under Certain Circumstances, Co To Pay Intermedix Reverse Termination Fee Of $23 MlnBRIEF-R1 RCM Says If Deal Terminated Under Certain Circumstances, Co To Pay Intermedix Reverse Termination Fee Of $23 Mln
www.reuters.com - February 26 at 9:38 AM
Form 4 R1 RCM INC. For: Feb 16 Filed by: FLANAGAN JOSEPH GERARDForm 4 R1 RCM INC. For: Feb 16 Filed by: FLANAGAN JOSEPH GERARD
www.streetinsider.com - February 17 at 9:11 AM
Presence Health Selects R1 RCM for End-to-End Revenue Cycle ManagementPresence Health Selects R1 RCM for End-to-End Revenue Cycle Management
finance.yahoo.com - February 16 at 9:20 AM
Brokerages Expect R1 RCM Inc (RCM) to Announce $0.02 Earnings Per ShareBrokerages Expect R1 RCM Inc (RCM) to Announce $0.02 Earnings Per Share
www.americanbankingnews.com - February 13 at 9:08 AM
R1 RCM (RCM) Raised to "Buy" at BidaskClubR1 RCM (RCM) Raised to "Buy" at BidaskClub
www.americanbankingnews.com - January 27 at 12:52 AM
Intermountain Healthcare Selects R1 for Integrated, Enterprise-wide Revenue CycleIntermountain Healthcare Selects R1 for Integrated, Enterprise-wide Revenue Cycle
finance.yahoo.com - January 24 at 9:22 AM
R1 RCM (RCM) Rating Lowered to Hold at BidaskClubR1 RCM (RCM) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - January 21 at 1:34 PM
Zacks Investment Research Downgrades R1 RCM (RCM) to SellZacks Investment Research Downgrades R1 RCM (RCM) to Sell
www.americanbankingnews.com - January 17 at 12:44 PM
R1 RCM (RCM) Upgraded at BidaskClubR1 RCM (RCM) Upgraded at BidaskClub
www.americanbankingnews.com - January 14 at 10:30 PM
 R1 RCM Inc (RCM) Given $5.00 Average Price Target by Brokerages R1 RCM Inc (RCM) Given $5.00 Average Price Target by Brokerages
www.americanbankingnews.com - January 12 at 3:16 AM
R1 RCM (RCM) Downgraded by BidaskClub to BuyR1 RCM (RCM) Downgraded by BidaskClub to Buy
www.americanbankingnews.com - January 5 at 10:20 PM
BRIEF-TCP-ASC ACHI Series LLLP - Exploring With R1 RCM Inc Possible Provision Of Debt, Equity Financing In Connection With Potential Acquisition By CoBRIEF-TCP-ASC ACHI Series LLLP - Exploring With R1 RCM Inc Possible Provision Of Debt, Equity Financing In Connection With Potential Acquisition By Co
www.reuters.com - January 4 at 4:16 PM
BidaskClub Upgrades R1 RCM (RCM) to "Strong-Buy"BidaskClub Upgrades R1 RCM (RCM) to "Strong-Buy"
www.americanbankingnews.com - December 27 at 11:48 AM
 R1 RCM Inc (RCM) Receives Average Rating of "Buy" from Brokerages R1 RCM Inc (RCM) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - December 25 at 11:40 AM
R1 RCM to Present at the 36th Annual J.P. Morgan Healthcare ConferenceR1 RCM to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 20 at 10:42 AM
Analysts Anticipate R1 RCM Inc (RCM) to Announce $0.01 EPSAnalysts Anticipate R1 RCM Inc (RCM) to Announce $0.01 EPS
www.americanbankingnews.com - December 20 at 3:22 AM
ETFs with exposure to R1 RCM, Inc. : December 12, 2017ETFs with exposure to R1 RCM, Inc. : December 12, 2017
finance.yahoo.com - December 12 at 4:13 PM
Critical Comparison: Examworks Group (EXAM) and R1 RCM (RCM)Critical Comparison: Examworks Group (EXAM) and R1 RCM (RCM)
www.americanbankingnews.com - December 9 at 8:04 AM
LHC Group (LHCG) versus Accretive Health (RCM) Head to Head ContrastLHC Group (LHCG) versus Accretive Health (RCM) Head to Head Contrast
www.americanbankingnews.com - December 7 at 1:16 PM
Head to Head Comparison: LHC Group (LHCG) versus Accretive Health (RCM)Head to Head Comparison: LHC Group (LHCG) versus Accretive Health (RCM)
www.americanbankingnews.com - December 4 at 9:34 PM

SEC Filings

R1 RCM (NASDAQ:RCM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

R1 RCM (NASDAQ:RCM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

R1 RCM (NASDAQ RCM) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.